Skip to main content

Closed

DMRA: Damora Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-46.7%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio22.48×

Damora Therapeutics, Inc.

DMRANASDAQ Capital Market·USD·Closed

Damora Therapeutics, Inc.

DMRANASDAQ·USD·Closed

$28.99

−0.75%

$28.99

−$0.22 (0.75%)

52W Range

74thpctl

Volume

0.54×avg

Mkt Cap

1.78BUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

74thpctl

Volume

0.54×avg

Market Cap

1.78BUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings